Benefit of heparin plus aspirin vs aspirin alone in unstable angina.

Benefit of heparin plus aspirin vs aspirin alone in unstable angina.

Detalles Bibliográficos
Main Authors:	Collins, R, Baigent, C, Peto, R
Formato:	Journal article
Idioma:	English
Publicado:	1996

Títulos similares

Benefit of aspirin plus angiotensin-converting enzyme inhibitor.
por: Baigent, C, et al.
Publicado: (2001)

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
por: Collins, R, et al.
Publicado: (1997)

ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION
por: Hunt, D, et al.
Publicado: (1992)

Atraumatic splenic rupture after administering aspirin, clopidogrel, and heparin to a patient with unstable angina: A case report
por: Iyad Maqboul, et al.
Publicado: (2024-06-01)

Immediate aspirin for suspected ischaemic stroke.
por: Baigent, C, et al.
Publicado: (1999)

Comparison of Two Therapeutic Protocols : Heparin with Aspirin VS Prednisolone with Aspirin, in Patients with Recurrent Miscarriages
por: S. Rabiee, M.D., et al.
Publicado: (2007-01-01)

Hydroxycarbamide plus Aspirin vs Aspirin alone in patients with essential Thrombocythaemia aged 40-59 years without high-risk features
por: Buck, G, et al.
Publicado: (2018)

Aspirin in the primary prevention of vascular disease Reply
por: Baigent, C, et al.
Publicado: (2009)

Aspirin in the primary prevention of vascular disease Reply
por: Baigent, C, et al.
Publicado: (2009)

Aspirin and stroke.
por: Buring, J, et al.
Publicado: (1990)

Economic Evaluation of Ticagrelor Plus Aspirin Versus Aspirin Alone for Acute Ischemic Stroke and Transient Ischemic Attack
por: Jigang Chen, et al.
Publicado: (2022-03-01)

Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared With Aspirin Alone in Patients With Coronary and Peripheral Artery Diseases in Italy
por: Shalin Rawal, et al.
Publicado: (2022-06-01)

The efficacy and adverse reaction of bleeding of clopidogrel plus aspirin as compared to aspirin alone after stroke or TIA: a systematic review.
por: Yan Huang, et al.
Publicado: (2013-01-01)

Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis.
por: Shuai Tan, et al.
Publicado: (2015-01-01)

ASPIRIN AND THE STOMACH - REPLY
por: Doll, R, et al.
Publicado: (1981)

ASPIRIN USE AND CHRONIC DISEASES
por: Hennekens, C, et al.
Publicado: (1990)

Aspirin and transient ischaemic attacks.
por: Peto, R, et al.
Publicado: (1979)

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
por: Patrono, C, et al.
Publicado: (2010)

Variability in aspirin efficacy: all in the genes?
por: Baigent, C, et al.
Publicado: (2019)

Aspirin for everyone older than 50? Against.
por: Baigent, C
Publicado: (2005)

Low-dose aspirin for the prevention of atherothrombosis.
por: Patrono, C, et al.
Publicado: (2005)

Aspirin in ischemic heart disease.
por: Hennekens, C, et al.
Publicado: (1992)

Effect of Opium Addiction on Aspirin Resistance in Stable Angina Pectoris
por: Afsaneh Forood, et al.
Publicado: (2014-01-01)

Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial
por: Ying Chen, et al.
Publicado: (2022-04-01)

Role of aspirin in primary prevention of cardiovascular disease
por: Patrono, C, et al.
Publicado: (2019)

Aspirin for disease prevention: public policy or personal choice?
por: Baigent, C
Publicado: (2016)

RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
por: Collins, R, et al.
Publicado: (1987)

RANDOMIZED FACTORIAL TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
por: Collins, R
Publicado: (1987)

Low-dose aspirin for migraine prophylaxis.
por: Buring, J, et al.
Publicado: (1990)

An overview of the British and American aspirin studies.
por: Hennekens, C, et al.
Publicado: (1988)

Drug therapy - Low-dose aspirin for the prevention of atherothrombosis
por: Patrono, C, et al.
Publicado: (2005)

Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
por: Mojtaba Khazaei, et al.
Publicado: (2019-03-01)

Critical Overview on the Benefits and Harms of Aspirin
por: Chun Shing Kwok, et al.
Publicado: (2010-05-01)

Prevention. Aspirin in primary prevention--good news and bad news.
por: Hennekens, C, et al.
Publicado: (2012)

Prevention: Aspirin in primary prevention-good news and bad news
por: Hennekens, C, et al.
Publicado: (2012)

HEPARIN THERAPY IN PATIENT WITH NON-Q WAVE MYOCARDIAL INFARCTION AND UNSTABLE ANGINA
por: M.H EMAMI, et al.
Publicado: (2000-03-01)

Association between eupatilin and reduction in small bowel bleeding in aspirin users and aspirin plus acid suppressant users
por: Hyun Seok Lee, et al.
Publicado: (2023-07-01)

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
por: Hennekens, C, et al.
Publicado: (1989)

Panax notoginseng preparation plus aspirin versus aspirin alone on platelet aggregation and coagulation in patients with coronary heart disease or ischemic stroke: A meta-analysis of randomized controlled trials
por: Lulu Dai, et al.
Publicado: (2022-12-01)

Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): A randomised, open-label, blinded-endpoint trial
por: Wong, K.S.L., et al.
Publicado: (2010)